These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24002183)

  • 1. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients.
    Hu N; Tan MS; Yu JT; Sun L; Tan L; Wang YL; Jiang T; Tan L
    J Alzheimers Dis; 2014; 38(3):497-501. PubMed ID: 24002183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease.
    Ozaki Y; Yoshino Y; Yamazaki K; Sao T; Mori Y; Ochi S; Yoshida T; Mori T; Iga JI; Ueno SI
    J Psychiatr Res; 2017 Sep; 92():74-80. PubMed ID: 28412600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
    Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
    Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus.
    Celarain N; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Larumbe R; Pulido L; Echavarri C; Mendioroz M
    Clin Epigenetics; 2016; 8():37. PubMed ID: 27051467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
    Mori Y; Yoshino Y; Ochi S; Yamazaki K; Kawabe K; Abe M; Kitano T; Ozaki Y; Yoshida T; Numata S; Mori T; Iga J; Kuroda N; Ohmori T; Ueno S
    PLoS One; 2015; 10(9):e0136835. PubMed ID: 26332043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
    Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
    Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
    Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
    J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
    Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
    Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
    Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
    Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration.
    Fenoglio C; Galimberti D; Piccio L; Scalabrini D; Panina P; Buonsanti C; Venturelli E; Lovati C; Forloni G; Mariani C; Bresolin N; Scarpini E
    Neurosci Lett; 2007 Jan; 411(2):133-7. PubMed ID: 17088018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous TREM2 mutations in frontotemporal dementia.
    Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A
    Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the value of plasma BIN1 as a potential biomarker for alzheimer's disease.
    Sun L; Tan MS; Hu N; Yu JT; Tan L
    J Alzheimers Dis; 2013; 37(2):291-5. PubMed ID: 23803295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Liu W; Wang X
    Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice.
    Jiang T; Yu JT; Zhu XC; Tan MS; Gu LZ; Zhang YD; Tan L
    Neurobiol Aging; 2014 Jun; 35(6):1243-51. PubMed ID: 24368090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression.
    Sirkis DW; Bonham LW; Aparicio RE; Geier EG; Ramos EM; Wang Q; Karydas A; Miller ZA; Miller BL; Coppola G; Yokoyama JS
    Acta Neuropathol Commun; 2016 Sep; 4(1):98. PubMed ID: 27589997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.
    Song W; Hooli B; Mullin K; Jin SC; Cella M; Ulland TK; Wang Y; Tanzi RE; Colonna M
    Alzheimers Dement; 2017 Apr; 13(4):381-387. PubMed ID: 27520774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients.
    Hu N; Tan MS; Sun L; Jiang T; Wang YL; Tan L; Zhang W; Yu JT; Tan L
    Neurosci Lett; 2014 Mar; 563():51-4. PubMed ID: 24412678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased glutaminyl cyclase expression in peripheral blood of Alzheimer's disease patients.
    Valenti MT; Bolognin S; Zanatta C; Donatelli L; Innamorati G; Pampanin M; Zanusso G; Zatta P; Dalle Carbonare L
    J Alzheimers Dis; 2013; 34(1):263-71. PubMed ID: 23207485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 and the Progression of Alzheimer's Disease.
    Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
    Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
    Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
    Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.